Related Experiment Video
Updated: Jun 20, 2026
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
The NCCN clinical practice guidelines in oncology: a primer for users
1National Comprehensive Cancer Network, Rockledge, Pennsylvania, USA. winn@nccn.org
Abstract:
Guidelines are becoming increasingly important as potential tools in improving clinical decision making. Because oncology practice encompasses a large number of tumors and their variants and because each tumor is characterized by heterogeneous presentations and clinical evolutions, an oncology guidelines program must be large in scope. Oncology practice is slowly moving toward evidence-based status, but guideline developers still must rely on less than perfect information to achieve this scope. By formalizing the consensus process, the NCCN program relies on the expertise of a broad range of cancer specialists to interpret the major clinical studies and apply their evaluative skills in assessing the relevance of these studies to clinical practice. In areas in which data are meager or contradictory, these experts are still charged with making recommendations if they believe their collective clinical experience points to a reasonable approach to disease management. It follows, therefore, that guidelines represent one of the most dynamic areas in medicine. The annual review process is designed to incorporate change as new evidence or innovative therapies become available. Therefore, the guidelines should be a true reflection of the state-of-the-art in oncology. The ultimate goal, as always, is improving care for the cancer patient.
Insights
Clinical guidelines are crucial for improving cancer care. The National Comprehensive Cancer Network (NCCN) program uses expert consensus to create dynamic, evidence-based oncology guidelines, ensuring up-to-date patient management.
Area of Science:
- Oncology
- Medical Guidelines
- Clinical Decision Making
Background:
- Clinical guidelines are essential tools for enhancing decision-making in healthcare.
- Oncology practice is complex due to numerous tumor types, heterogeneous presentations, and varied clinical progressions.
- The development of evidence-based oncology practice is ongoing, often requiring reliance on imperfect data.
Purpose of the Study:
- To outline the scope and methodology of a comprehensive oncology guidelines program.
- To emphasize the role of expert consensus in developing clinical recommendations.
- To highlight the dynamic nature of oncology guidelines in reflecting the state-of-the-art in cancer care.
Main Methods:
- Formalizing a consensus process involving a broad range of cancer specialists.
- Interpreting major clinical studies and assessing their relevance to clinical practice.
- Incorporating collective clinical experience to make recommendations in areas with limited or contradictory data.
Main Results:
- The NCCN program leverages expert consensus to create guidelines for diverse oncology scenarios.
- Guidelines are developed even when data are sparse, relying on expert judgment for reasonable disease management approaches.
- An annual review process ensures guidelines remain current with new evidence and therapies.
Conclusions:
- Oncology guidelines are a dynamic and vital component of modern medicine.
- Expert-driven consensus processes are crucial for developing relevant and practical cancer care recommendations.
- The ultimate aim of these guidelines is to improve patient outcomes in oncology.
Related Concept Videos
01:21Cancer Survival Analysis
01:27Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:29Nursing Interventions II: Selecting and Classifying the Nursing Interventions
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...